To determine which kinase upstream of eIF2α is driving the effects of ISR activation following Ref-1 inhibition, GCN2, PERK, PKR as well as HRI were knocked down in human pancreatic cancer cells, Pa03C using siRNA and subsequently treated with APX2009 for 6 h. The gene discussed is EIF2A; the disease is pancreatic neoplasm.